Major Depression (MDD) is one of the most common conditions on the planet. Approximately 17.3 million adults across America suffer a depressive episode during any given year. Worldwide, it affects 300 million people.
In some people, antidepressant SSRIs and SNRIs effectively resolve MDD symptoms. However, these medications do not work for everyone—especially since symptoms can vary from person to person—from loss of interest in once pleasurable things to insomnia and fatigue. Thus, there continues to be an unmet need for new drug therapies.
But you can do something. Right now, experts are evaluating investigational MDD medications. For yourself, for those you love, and for future generations, please consider volunteering for clinical trials. Join the fight against MDD. Together, we could help change lives.
Tell us a little bit about yourself
Answer some questions about your health
We will connect you to available studies in your area
For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.
AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.